Dr. Anna Kushnir is a leader in translational medicine, overseeing the preclinical development of vaccines at Codagenix. Currently, they serve as the Director of Translational Medicine at AstraZeneca and as the Board President of LEAS LAB Inc., an organization dedicated to bridging the knowledge gap in science among diverse socioeconomic groups. Dr. Kushnir holds a PhD in Virology from Harvard University and a B.A. in Biology from the University of Virginia.
This person is not in any teams
This person is not in any offices